ZEAL — Zealand Pharma A/S Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapContrarian

Annual balance sheet for Zealand Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,428	1,178	1,633	8,226	15,109
Net Total Accounts Receivable
Net Total Receivables	110	82.8	111	176	305
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,722	1,316	1,780	8,528	15,670
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	221	165	150	125	151
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,068	1,540	1,980	9,506	15,949
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	334	195	285	403	665
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,140	724	387	889	1,118
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	928	816	1,593	8,617	14,831
Total Liabilities & Shareholders' Equity	2,068	1,540	1,980	9,506	15,949
Total Common Shares Outstanding